Intercept Pharmaceuticals Inc (NASDAQ:ICPT) - Share price - Overview

Stock Report

Intercept Pharmaceuticals Inc ICPT

Last Price
$60.73

Day Change
0.83|1.39%

As of 17/11/2017
16:30:00 EST | USD
Minimum 15 Minutes Delay.

Last Close59.90
Day Range59.51 - 61.22
Mkt Cap1.52Bil
52-Wk Range54.98 - 135.59
Yield %-
ISINUS45845P1084
Volume505,141
P/E-4.10
P/S14.16
P/CF-5.45

Share Price

Financials
201420152016
More ...
Income Statement
Revenue1.742.7824.95
Operating Income-113.17-229.16-402.54
Net Income-283.23-226.43-412.83
Basic EPS-13.63-9.56-16.74
Avg. Diluted Shares Outstanding212425
Balance Sheet
Current Assets245.83641.69707.87
Non Current Assets8.3214.0731.39
Total Assets254.15655.76739.25
Current Liabilities15.2447.3778.51
Total Liabilities23.2653.61424.32
Total Equity230.89602.15314.93
Cash Flow
Operating Cash Flow-87.74-162.90-342.44
Capital Expenditure-4.64-5.94-5.08
Free Cash Flow-92.38-168.84-347.52

In millions, except "Basic EPS". Currency is USD.

Company Profile

Intercept Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases with high unmet medical need.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

456
Key Stats
More ...
Price/Earning TTM-4.05
Price/Book13.47
Price/Sales TTM21.01
Rev Growth (3 year avg)148.72
EPS Growth (3 year avg)-
Operating Margin % TTM-1,613.31
Net Margin % TTM-1,654.56
ROE TTM-90.03
Debt/Equity1.08
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.